Literature DB >> 23220354

Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients.

Thomas Wilke1, Antje Groth, Sabrina Mueller, Matthias Pfannkuche, Frank Verheyen, Roland Linder, Ulf Maywald, Rupert Bauersachs, Günter Breithardt.   

Abstract

AIMS: Based on an analysis of claims-based data of 8.298 million members of two German statutory health insurance funds, the aim of this contribution is to quantify age-/gender-specific prevalence/incidence of atrial fibrillation (AF) in a German setting. METHODS AND
RESULTS: Patients were classified as AF prevalent, if they had received at least two outpatient diagnoses of AF (ICD10-Code I48.1-) in two different quarters of the year and/or had received at least one main AF diagnosis during inpatient treatment between 1 January 2007 and 12 December 2008. They were considered to have had new onset AF in 2008 under the following conditions; first, there was no AF diagnosis in 2007; secondly, patients had not received oral anticoagulant medication in 2007; and thirdly, patients had received either one inpatient/two outpatient diagnoses of AF in 2008. In our sample, a total of 176 891 patients had AF. AF prevalence was 2.132%. The average age of these AF patients was 73.1 years, and 55.5% (98 190 patients) were male. The incidence of AF in our sample was 4.358 cases/1000 person-years in men and 3.868 cases/1000 person-years in women.
CONCLUSION: A comparison of the distribution of AF prevalence/incidence in our population with that in already published studies showed that our figures were higher, especially in the age groups above 70 years. Our data show that in a large industrial nation such as Germany care provision structures are going to be challenged by a requirement to treat more AF patients in the future.

Entities:  

Mesh:

Year:  2012        PMID: 23220354     DOI: 10.1093/europace/eus333

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  106 in total

1.  Maze permutations during minimally invasive mitral valve surgery.

Authors:  Anson M Lee
Journal:  Ann Cardiothorac Surg       Date:  2015-09

2.  Outcome of older hip fracture patients on anticoagulation: a comparison of vitamin K-antagonists and Factor Xa inhibitors.

Authors:  M Gosch; M Jacobs; H Bail; S Grueninger; S Wicklein
Journal:  Arch Orthop Trauma Surg       Date:  2020-07-24       Impact factor: 3.067

3.  [Thromboembolism prophylaxis in old age].

Authors:  Gabriele Röhrig; Gerald Kolb
Journal:  Z Gerontol Geriatr       Date:  2018-04-05       Impact factor: 1.281

Review 4.  Catheter ablation versus anti-arrhythmic drug therapy for the management of a trial fibrillation: a meta-analysis.

Authors:  Xiaofeng Cheng; Xiaoqing Li; Yun He; Xiaoyan Liu; Guoqiang Wang; Li Cheng; Jianbo Hu
Journal:  J Interv Card Electrophysiol       Date:  2014-12-04       Impact factor: 1.900

5.  Atrial fibrillation and oral anticoagulation in older people with frailty: a nationwide primary care electronic health records cohort study.

Authors:  Chris Wilkinson; Andrew Clegg; Oliver Todd; Kenneth Rockwood; Mohammad E Yadegarfar; Chris P Gale; Marlous Hall
Journal:  Age Ageing       Date:  2020-12-16       Impact factor: 10.668

6.  Elevated glycated hemoglobin levels may increase the risk of atrial fibrillation in patients with diabetes mellitus.

Authors:  Yu-Fan Yang; Wen-Qing Zhu; Kuan Cheng; Qing-Xing Chen; Ye Xu; Yang Pang; Gui-Jian Liu; Jun-Bo Ge
Journal:  Int J Clin Exp Med       Date:  2015-03-15

7.  Assessment of Sex Differences in the Initial Symptom Burden, Applied Treatment Strategy, and Quality of Life in Japanese Patients With Atrial Fibrillation.

Authors:  Nobuhiro Ikemura; Shun Kohsaka; Takehiro Kimura; Ikuko Ueda; Yoshinori Katsumata; Takahiko Nishiyama; Yoshiyasu Aizawa; Kojiro Tanimoto; Yukihiko Momiyama; Makoto Akaishi; Hideo Mitamura; Keiichi Fukuda; John A Spertus; Seiji Takatsuki
Journal:  JAMA Netw Open       Date:  2019-03-01

Review 8.  Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis.

Authors:  Darae Ko; Faisal Rahman; Renate B Schnabel; Xiaoyan Yin; Emelia J Benjamin; Ingrid E Christophersen
Journal:  Nat Rev Cardiol       Date:  2016-04-07       Impact factor: 32.419

9.  Monogenic and Polygenic Contributions to Atrial Fibrillation Risk: Results From a National Biobank.

Authors:  Seung Hoan Choi; Sean J Jurgens; Lu-Chen Weng; James P Pirruccello; Carolina Roselli; Mark Chaffin; Christina J-Y Lee; Amelia W Hall; Amit V Khera; Kathryn L Lunetta; Steven A Lubitz; Patrick T Ellinor
Journal:  Circ Res       Date:  2019-11-06       Impact factor: 17.367

Review 10.  [Anticoagulation in geriatric patients with atrial fibrillation : With what and for whom no more?]

Authors:  P Bahrmann; M Christ
Journal:  Herz       Date:  2018-05       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.